Brief: Activist Elliott Investment Management Has Built A Sizable Stake In Bio-Rad Laboratories- WSJ
18/05/2026 01:28
May 17 (Reuters) - ACTIVIST ELLIOTT INVESTMENT MANAGEMENT HAS BUILT A SIZABLE STAKE IN BIO-RAD LABORATORIES- WSJ ELLIOTT IS ALSO A LARGE INVESTOR IN SARTORIUS, THE GERMAN SUPPLIER OF PHARMACEUTICAL EQUIPMENT THAT BIO-RAD HAS A STRATEGIC INVESTMENT IN- WSJ Source https://tinyurl.com/mfxxancp ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio-Rad Laboratories
See all newsBio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Bio-Rad Laboratories On July 31, Initiated Restructuring Plan - SEC Filing
Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth
Brief: Bio-Rad Q2 Net Income USD 371.4 Million
Activist investors make bigger push for campaigns in H1, seek more M&A